This seems to be the pointy end of the saga. It will be a really...

This seems to be the pointy end of the saga. It will be a really good test for the medical telehealth emarket players to respond over the next few weeks. We think we are a disruptive company with simple, proven technology; if we really are then some big player will make a counter offer. If not, well we long term shareholders will have to come to terms with the fact that our tech isn’t that special after all. I won’t believe it but I will have to accept it.

And if that is the case then I will have to change my no vote. Time is ticking.